Daniel Dickstein, M.D.
Daniel Dickstein, M.D., leads the Pediatric Mood, Imaging, & NeuroDevelopment (PediMIND) program at Bradley Hospital, one of the nation’s only freestanding hospitals devoted to the psychiatric care of children and adolescents. PediMIND’s goal is to identify biological and behavioral markers of psychiatric illness in children using affective neuroscience techniques, including behavioral tasks, multi-modal magnetic resonance imaging (MRI) scanning, detailed psychiatric assessments, and genetic assays. Dr. Dickstein is a graduate of the Brown University School of Medicine and completed a combined post-graduate residency at Brown in pediatrics, general psychiatry, and child/adolescent psychiatry. He is now board-certified in all three fields. Before starting the PediMIND program in 2007, Dr. Dickstein was a fellow at the National Institute of Mental Health’s Division of Intramural Research Programs (NIMH DIRP). Dr. Dickstein is the recipient of many awards, including the 2004 NIMH DIRP Richard J. Wyatt Memorial Fellowship Training Award for outstanding scientific accomplishment, a 2009 NIMH Bio-behavioral Research Award for Innovative New Investigators (BRAINS) Award, and a 2010 NARSAD Gerald L. Klerman, M.D., Award for outstanding clinical research achievement.
The Diagnostic DilemmaWhy We Need to Change How We Diagnose Bipolar Disorder in Children
Bipolar disorder diagnosis has been rising dramatically in children for the past decade.In coming years, argues Daniel Dickstein, M.D., recognizing and diagnosing bipolar disorder in children should be based more on biological markers, such as brain structure and the use of neural circuits, than on the inconsistent diagnostic categories laid out in the Diagnostic and Statistical Manual of Mental Disorders.